심초음파 시장 규모, 점유율, 성장 및 세계 업계 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of echocardiography market Market

The global echocardiography market, which encompasses devices used to perform cardiac ultrasounds, was valued at USD 2.13 billion in 2025 and is projected to grow to USD 2.29 billion in 2026, ultimately reaching USD 4.07 billion by 2034, reflecting a CAGR of 7.45% during the forecast period of 2026-2034. North America dominated the market in 2025 with a 24.85% share, driven by the rising prevalence of coronary and peripheral heart diseases, an increasing geriatric population, and strong presence of key industry players.

Echocardiography, also referred to as an echo or cardiac ultrasound, utilizes sound waves to create images of the heart for detecting cardiovascular diseases. The technology allows the identification of blood clots, assessment of heart chambers, and evaluation of valves. Among various tests, transthoracic echocardiography is the most common due to its non-invasive nature. Other modalities include transesophageal and stress echocardiography, used for specialized diagnostic purposes.

Market Growth Drivers

The market growth is primarily fueled by the rising burden of heart-related disorders and the increasing demand for non-invasive diagnostic procedures. Cardiovascular conditions such as heart arrhythmias, valve diseases, heart failure, and pericardial diseases are increasing globally due to sedentary lifestyles, unhealthy diets, and smoking. According to the CDC, approximately 805,000 people in the U.S. experience a heart attack annually, with 605,000 being first-time events. In Europe, over half of all deaths are linked to cardiovascular disease, contributing to more than 60 million potential years of life lost each year.

Early detection initiatives and preventive healthcare programs also support market growth. Programs such as Million Hearts, co-led by the U.S. CDC and CMS, aim to reduce myocardial infarction and cardiac stroke rates by 2027, boosting demand for echocardiography devices. The non-invasive nature of these devices provides advantages over other cardiac diagnostic procedures like cardiac catheterization, MRI, or nuclear stress tests, which carry higher risks and costs. Echocardiography is also extensively used in monitoring patients undergoing cancer treatment due to cardiotoxicity risks.

Technological Advancements

Technological innovation, particularly the incorporation of AI and 3D/4D imaging, is enhancing the market potential. AI improves diagnostic accuracy, workflow efficiency, and patient outcomes. For example, in December 2021, Koninklijke Philips N.V. launched an AI-driven auto-measure application in its EPIQ CVx and Affiniti CVx systems, reducing measurement time by half. Similarly, Ultromics and Pfizer received FDA clearance in January 2024 for the EchoGo Amyloidosis AI algorithm.

The adoption of handheld devices and point-of-care solutions is also rising. In June 2022, Clarius Mobile Health partnered with ImaCor Inc. to launch a handheld transesophageal cardiac ultrasound scanner for ICU patients. These innovations improve access and convenience, driving demand across hospitals and diagnostic centers.

Market Segmentation

• By Device Type: Cart-based devices dominated with a 68.73% share in 2026 due to their advanced imaging capabilities and hospital adoption. Handheld devices are projected to grow significantly during the forecast period.
• By Test Type: Transthoracic echocardiography accounted for 77.65% in 2026, while stress echocardiography is expected to grow fastest due to the rising prevalence of coronary artery disease.
• By Technology: 2D devices led with a 60.7% share in 2026, whereas 3D & 4D devices are expanding due to high-resolution imaging and enhanced anatomical visualization.
• By End-User: Hospitals and ambulatory surgical centers generated the highest revenue and are expected to maintain dominance with a 76.76% market share in 2026, driven by increasing patient visits. Diagnostic centers are growing due to global expansion efforts.

Regional Insights

• North America: Market size USD 0.53 billion in 2025, projected USD 0.57 billion in 2026, led by the U.S. market (USD 0.54 billion in 2026).
• Europe: Market size USD 0.47 billion in 2025, projected USD 0.51 billion in 2026, driven by improved infrastructure and high adoption rates.
• Asia Pacific: Market size USD 0.99 billion in 2025, projected USD 1.07 billion in 2026, fastest-growing due to rising CVD prevalence. Key markets include Japan (USD 0.34 billion), China (USD 0.38 billion), and India (USD 0.11 billion).
• Middle East & Africa: USD 0.06 billion in 2025 and 2026, modest growth.
• Latin America: USD 0.08 billion in 2025, reaching USD 0.09 billion in 2026.

Key Players

Major companies in the echocardiography market include:

• General Electric Company (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Canon Medical Systems Corporation (Canon Inc.) (Japan)
• FUJIFILM Holdings Corporation (Japan)
• Siemens Healthineers AG (Germany)
• Boston Scientific Corporation (U.S.)
• SAMSUNG ELECTRONICS Co., Ltd. (Korea)
• ESAOTE SPA (Italy)
• CHISON Medical Technologies Co., Ltd (China)

These companies are actively involved in R&D, new product launches, and AI integration to enhance diagnostic efficiency and expand market share.

Market Restraints

Despite growth, high device costs (ranging from USD 20,000 to 100,000) and limitations in handheld devices, such as smaller screens and lower resolution, may restrict adoption in certain regions. Echocardiogram procedures can cost between USD 1,000 to over USD 3,000, depending on test type, insurance, and healthcare facility.

Conclusion

The echocardiography market is poised for robust growth from 2026 to 2034, driven by the rising prevalence of cardiovascular diseases, demand for non-invasive diagnostics, technological advancements in AI and 3D imaging, and increased adoption in hospitals and diagnostic centers worldwide.

Growth Rate CAGR of 7.45% from 2026-2034

Segmentation By Device Type

• Cart Based
• Handheld

By Test Type

• Transthoracic Echocardiography
• Transesophageal Echocardiography
• Stress Echocardiography
• Others

By Technology

• 2D
• 3D & 4D
• Doppler Imaging

By End-user

• Hospitals & ASCs
• Diagnostic Center
• Others

By Geography

• North America (By Device Type, Test Type, Technology, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Device Type, Test Type, Technology, End-user, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Device Type, Test Type, Technology, End-user, and Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Device Type, Test Type, Technology, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Device Type, Test Type, Technology, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Cardiovascular Diseases, By Key Countries, 2025/2025
• 4.2. Technological Advancements in Echocardiography Market
• 4.3. New Product Launches, By Key Players
• 4.4. Key Industry Developments- Mergers, Partnerships, Acquisitions, etc.
• 4.5. Impact of COVID-19 on the Global Echocardiography Market

5. Global Echocardiography Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Device Type
  • 5.1.1. Cart Based
  • 5.1.2. Handheld
• 5.2. Market Analysis, Insights and Forecast - By Test Type
  • 5.2.1. Transthoracic Echocardiography
  • 5.2.2. Transoesophageal Echocardiography
  • 5.2.3. Stress Echocardiography
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Technology
  • 5.3.1. 2D
  • 5.3.2. 3D & 4D
  • 5.3.3. Doppler Imaging
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Diagnostic Center
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Echocardiography Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Device Type
  • 6.1.1. Cart Based
  • 6.1.2. Handheld
• 6.2. Market Analysis, Insights and Forecast - By Test Type
  • 6.2.1. Transthoracic Echocardiography
  • 6.2.2. Transoesophageal Echocardiography
  • 6.2.3. Stress Echocardiography
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Technology
  • 6.3.1. 2D
  • 6.3.2. 3D & 4D
  • 6.3.3. Doppler Imaging
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Diagnostic Center
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Echocardiography Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Device Type
  • 7.1.1. Cart Based
  • 7.1.2. Handheld
• 7.2. Market Analysis, Insights and Forecast - By Test Type
  • 7.2.1. Transthoracic Echocardiography
  • 7.2.2. Transoesophageal Echocardiography
  • 7.2.3. Stress Echocardiography
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Technology
  • 7.3.1. 2D
  • 7.3.2. 3D & 4D
  • 7.3.3. Doppler Imaging
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Diagnostic Center
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. Germany
  • 7.5.2. U.K.
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Echocardiography Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Device Type
  • 8.1.1. Cart Based
  • 8.1.2. Handheld
• 8.2. Market Analysis, Insights and Forecast - By Test Type
  • 8.2.1. Transthoracic Echocardiography
  • 8.2.2. Transoesophageal Echocardiography
  • 8.2.3. Stress Echocardiography
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Technology
  • 8.3.1. 2D
  • 8.3.2. 3D & 4D
  • 8.3.3. Doppler Imaging
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Diagnostic Center
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. China
  • 8.5.2. India
  • 8.5.3. Japan
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Echocardiography Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Device Type
  • 9.1.1. Cart Based
  • 9.1.2. Handheld
• 9.2. Market Analysis, Insights and Forecast - By Test Type
  • 9.2.1. Transthoracic Echocardiography
  • 9.2.2. Transoesophageal Echocardiography
  • 9.2.3. Stress Echocardiography
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Technology
  • 9.3.1. 2D
  • 9.3.2. 3D & 4D
  • 9.3.3. Doppler Imaging
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Diagnostic Center
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Echocardiography Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Device Type
  • 10.1.1. Cart Based
  • 10.1.2. Handheld
• 10.2. Market Analysis, Insights and Forecast - By Test Type
  • 10.2.1. Transthoracic Echocardiography
  • 10.2.2. Transoesophageal Echocardiography
  • 10.2.3. Stress Echocardiography
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Technology
  • 10.3.1. 2D
  • 10.3.2. 3D & 4D
  • 10.3.3. Doppler Imaging
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Diagnostic Center
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. South Africa
  • 10.5.2. GCC
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. FUJIFILM Holdings Corporation
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Koninklijke Philips N.V.
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Boston Scientific Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Canon Medical Systems Corporation (Canon Inc.)
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. ESAOTE SPA
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. CHISON Medical Technologies Co., Ltd
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. SAMSUNG ELECTRONICS Co., Ltd.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Siemens Healthineers AG
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. General Electric Company
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)